Aldeyra Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -3.04%
- Market cap
- $37.73M
- 60.36M shares
- Filings
- 654
—
—
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
FY 2023derivedN/M FY23 yoy
Q3 2026N/M FY25 yoy
Q3 2026+28.5% FY25 yoy
- $37.73M
- —
- —
- 1.1×
- —
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $25,662,855 | reported | |
| FY 2024 | 2024-12-31 | $48,224,793 | reported | |
| FY 2023 | 2023-12-31 | $29,458,719 | reported | |
| FY 2022 | 2022-12-31 | $47,306,066 | reported | |
| FY 2021 | 2021-12-31 | $44,936,532 | reported | |
| FY 2020 | 2020-12-31 | $24,681,301 | reported | |
| FY 2019 | 2019-12-31 | $44,351,851 | reported | |
| FY 2018 | 2018-12-31 | $29,823,007 | reported | |
| FY 2017 | 2017-12-31 | $16,302,568 | reported | |
| FY 2016 | 2016-12-31 | $13,175,670 | reported | |
| FY 2015 | 2015-12-31 | $7,574,398 | reported | |
| FY 2014 | 2014-12-31 | $3,707,544 | reported |
Pharmaceutical preparations
Aldeyra Therapeutics, Inc. is the 348th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
BHSTBioharvest Sciences Inc.$34.5M37.0%32.3%$39.7MGRCEGrace Therapeutics, Inc.———$38.0MATHEAlterity Therapeutics Ltd———$37.9M
ALDXAldeyra Therapeutics, Inc. (this company)———$37.7M
SERSerina Therapeutics, Inc.$130.0K132.1%14,755.4%$37.7MAPLMApollomics Inc.Fiscal 2024 figures———$37.6MVERUVeru Inc.———$36.1MTELOTelomir Pharmaceuticals, Inc.———$36.1MANVSAnnovis Bio, Inc.$0.0——$35.7MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Aldeyra Therapeutics, Inc. · CIK 1341235 · Engraved from SEC EDGAR